In this report, we aimed to explore the role of Arl4c in pancreatic cancer growth and drug resistance, as well as PSC activation, further determine its effect on tumor-stromal interactions, and reveal the underlying mechanism. The gene discussed is ARL4C; the disease is familial pancreatic carcinoma.